학술논문
Immunogenicity and safety of SARS-CoV-2 recombinant protein nanoparticle vaccine GBP510 adjuvanted with AS03: interim results of a randomised, active-controlled, observer-blinded, phase 3 trial
Document Type
Article
Author
Philippot, Agathe; Solmi, Francesca; Ceregido, Maria Angeles; Shim, Byoung-Shik; Seo, Sang Hwan; D'Souza, Simone; Thaisrivichai, Patchara; Carlos, Josefina; Alberto, Edison; Nitayaphan, Sorachai; Ratanasuwan, Winai; Mootsikapun, Piroon; Chaiwarith, Romanee; Chan Quang, Luong; Karpenko, Olena; Yurkiv, Tatiana; Kutovyi, Vitalii; Bartko, Angela; Gyrina, Olga; Barna, Olga; Pugach, Mykhailo; Thurlow, Claire; Carson, Simon; Smith, Susan; Williams, Mike; Hemi Senior, Tiwini; Humphrey, Tim; Sheahan, Davitt; Park, Hokeun; Lee, Yoon Yeong; Kang, Seung Gu; Song, Joon Young; Choi, Won Suk; Heo, Jung Yeon; Kim, Eun Jin; Lee, Jin Soo; Jung, Dong Sik; Kim, Shin-Woo; Park, Kyung-Hwa; Eom, Joong Sik; Jeong, Su Jin; Lee, Jacob; Kwon, Ki Tae; Choi, Hee Jung; Sohn, Jang Wook; Kim, Young Keun; Yoo, Byung Wook; Jang, In-Jin; Capeding, Maria Z.; Roman, François; Breuer, Thomas; Wysocki, Piotr; Carter, Lauren; Sahastrabuddhe, Sushant; Song, Manki; D'Cor, Naveena; Kim, Hun; Ryu, Ji Hwa; Lee, Su Jeen; Park, Yong Wook; Cheong, Hee Jin
Source
In eClinicalMedicine October 2023 64
Subject
Language
ISSN
2589-5370